Occuity (@occuity) 's Twitter Profile
Occuity

@occuity

Developing #optical #medtech screening & monitoring devices for some of humanity's greatest health challenges - #diabetes #myopia #glaucoma #alzheimers #pm1

ID: 1321766577990152193

linkhttps://www.occuity.com calendar_today29-10-2020 10:52:35

1,1K Tweet

3,3K Followers

3,3K Following

Occuity (@occuity) 's Twitter Profile Photo

Tomorrow, we find out if we were successful in the Hard Tech Investment of the Year category at the UKBAA Angel Investment Awards 2023! πŸŽ‰ A huge thank you to our incredible angel investors! πŸ’‘ #UKBAAAwards #Innovation #Healthcare #MedTech #Oculomics #AngelInvestors #Occuity

Tomorrow, we find out if we were successful in the Hard Tech Investment of the Year category at the UKBAA Angel Investment Awards 2023! πŸŽ‰

A huge thank you to our incredible angel investors! πŸ’‘

#UKBAAAwards #Innovation #Healthcare #MedTech #Oculomics #AngelInvestors #Occuity
Occuity (@occuity) 's Twitter Profile Photo

Exciting news! Our Senior Research Scientist, Dr. Alistair Bounds, was invited to write a feature for Physics World on oculomics. This highlights our work and the growing recognition of oculomics in health diagnostics. #HealthTech #Oculomics zurl.co/yJEI

Exciting news! Our Senior Research Scientist, Dr. Alistair Bounds, was invited to write a feature for <a href="/PhysicsWorld/">Physics World</a> on oculomics. This highlights our work and the growing recognition of oculomics in health diagnostics. #HealthTech #Oculomics
zurl.co/yJEI
Occuity (@occuity) 's Twitter Profile Photo

Thrilled to announce that Jamie Serjeant has won the RAEng Engineers Trust Young Engineer of the Year award! πŸ† Jamie’s groundbreaking work in optical diagnostics is revolutionising healthcare. Congrats, Jamie! 🌟 #EngineeringExcellence #RAEngAwards zurl.co/5Pk0

Occuity (@occuity) 's Twitter Profile Photo

We're delighted to announce that Occuity has received a Notice of Intent to Grant for 3 new patents! πŸŽ‰ These innovations will further our mission to revolutionise optical diagnostics for chronic conditions.πŸ‘οΈπŸ’‘ #MedTech #Innovation #HealthTech zurl.co/LhUU

We're delighted to announce that Occuity has received a Notice of Intent to Grant for 3 new patents! πŸŽ‰ These innovations will further our mission to revolutionise optical diagnostics for chronic conditions.πŸ‘οΈπŸ’‘ #MedTech #Innovation #HealthTech 

zurl.co/LhUU
Occuity (@occuity) 's Twitter Profile Photo

Responding to the recent BBC article on Alzheimer's treatments like Lecanemab, we explore the importance of early detection. Discover how we're innovating diagnosis in our latest blog. πŸ§ πŸ” ]#Alzheimers #HealthcareInnovation #EarlyDetection zurl.co/K8r1

Responding to the recent BBC article on Alzheimer's treatments like Lecanemab, we explore the importance of early detection. Discover how we're innovating diagnosis in our latest blog. πŸ§ πŸ” ]#Alzheimers #HealthcareInnovation #EarlyDetection zurl.co/K8r1
Occuity (@occuity) 's Twitter Profile Photo

Discover why optical biometry is the gold standard in myopia management. Accurate, non-invasive, and essential for better eye health outcomes. Learn more in our latest blog post! πŸ‘οΈπŸ‘‰ zurl.co/Y1sg #Myopia #EyeHealth #OpticalBiometry

Discover why optical biometry is the gold standard in myopia management. Accurate, non-invasive, and essential for better eye health outcomes. Learn more in our latest blog post! πŸ‘οΈπŸ‘‰ zurl.co/Y1sg #Myopia #EyeHealth #OpticalBiometry
Occuity (@occuity) 's Twitter Profile Photo

Productive days at #ESCRS2024 showcasing our PM1 and AX1! Hosted 25 meetings in 3 days with global distributors. Loved our visit to the Sagrada Familia too! Read more about our journey here: zurl.co/BZAG #ESCRS2024 #Ophthalmology

Productive days at #ESCRS2024 showcasing our PM1 and AX1! Hosted 25 meetings in 3 days with global distributors. Loved our visit to the Sagrada Familia too! 

Read more about our journey here: zurl.co/BZAG 

#ESCRS2024 #Ophthalmology
Occuity (@occuity) 's Twitter Profile Photo

πŸ† We’re honoured to have won National Medtech & Healthtech StartUp of the Year at the UK StartUp Awards! Our work in Oculomics continues to gain momentum as we transform healthcare diagnostics. Exciting times ahead! #Medtech #UKSA2024 #Oculomics πŸ”— zurl.co/i4yD

πŸ† We’re honoured to have won National Medtech &amp; Healthtech StartUp of the Year at the UK StartUp Awards! Our work in Oculomics continues to gain momentum as we transform healthcare diagnostics. Exciting times ahead! #Medtech  #UKSA2024 #Oculomics πŸ”— zurl.co/i4yD
Occuity (@occuity) 's Twitter Profile Photo

πŸš€ Exciting news! Occuity signs with Skymed Ltd. as the exclusive distributor for PM1 Pachymeter in Israel. Skymed's Tzah Kimchi says: "The PM1 is a remarkable device that will benefit glaucoma, refractive surgery clinics & more." zurl.co/AdWH #MedTech #Ophthalmology

πŸš€ Exciting news! Occuity signs with Skymed Ltd. as the exclusive distributor for PM1 Pachymeter in Israel. Skymed's Tzah Kimchi says: "The PM1 is a remarkable device that will benefit glaucoma, refractive surgery clinics &amp; more."

zurl.co/AdWH 
#MedTech #Ophthalmology
Occuity (@occuity) 's Twitter Profile Photo

πŸš€ BREAKING NEWS! Our PM1 Pachymeter just received CE Marking! This non-contact, handheld device is set to transform glaucoma screening. 🌍 Learn more about our journey to bring safer, faster eye care solutions to the world! πŸ‘‰ zurl.co/6NQQ #Glaucoma #optometry

πŸš€ BREAKING NEWS! Our PM1 Pachymeter just received CE Marking! This non-contact, handheld device is set to transform glaucoma screening. 🌍 Learn more about our journey to bring safer, faster eye care solutions to the world! πŸ‘‰ zurl.co/6NQQ  #Glaucoma #optometry
Occuity (@occuity) 's Twitter Profile Photo

In this video, Optometrist Jason Higginbotham introduces the PM1 Pachymeter – the first handheld, non-contact optical pachymeter. He covers setup, CCT measurement, and shares pro tips for effective use. #Optometry #PM1Pachymeter #EyeCare #glaucoma zurl.co/hY6O

Occuity (@occuity) 's Twitter Profile Photo

🌟 We lit up Occuity for Diwali! Celebrating the Festival of Lights with our diverse team, delicious food, and vibrant decor brought us closer and filled the office with joy. πŸŽ‰ Read more in our latest blog! #Diwali #TeamOccuity #WorkplaceCulture zurl.co/ZPsw

Occuity (@occuity) 's Twitter Profile Photo

Exciting news! Occuity partners with Von Hoff as the exclusive distributor for the PM1 #Pachymeter in Switzerland & Liechtenstein. CE certified, the PM1 revolutionises glaucoma care. πŸ‘‰ Read more here zurl.co/bg9VF #Ophthalmology #PM1 #Glaucoma #refractivesurgery

Exciting news! Occuity partners with Von Hoff as the exclusive distributor for the PM1 #Pachymeter in Switzerland &amp; Liechtenstein. CE certified, the PM1 revolutionises glaucoma care. πŸ‘‰ Read more here zurl.co/bg9VF 

#Ophthalmology #PM1 #Glaucoma #refractivesurgery
Occuity (@occuity) 's Twitter Profile Photo

Occuity is closing it's current investment round tomorrow - Friday, 20th December 2024. If you wish to take advantage of investing in this round before it closes, please visit zurl.co/3CMR5 . #investment #EIS #EQUITY #MEDTECH #MYOPIA

Occuity is closing it's current investment round tomorrow - Friday, 20th December 2024. If you wish to take advantage of investing in this round before it closes, please visit  zurl.co/3CMR5 .

#investment #EIS #EQUITY #MEDTECH #MYOPIA
Occuity (@occuity) 's Twitter Profile Photo

We’re excited to partner with Abioz Technologies as our exclusive distributor in France! πŸ‡«πŸ‡· Together, we’ll expand access to non-invasive optical technologies across Europe. 🌍 Read more here: zurl.co/OQWnk #Occuity #Partnership #gluacoma #myopia #PM1 #AX1 #France

We’re excited to partner with Abioz Technologies as our exclusive distributor in France! πŸ‡«πŸ‡· Together, we’ll expand access to non-invasive optical technologies across Europe. 🌍 

Read more here: zurl.co/OQWnk

#Occuity #Partnership #gluacoma #myopia #PM1 #AX1 #France
Occuity (@occuity) 's Twitter Profile Photo

πŸ’‘ China has reclassified Red Light Therapy for myopia, meaning existing treatments are no longer approved. But what does this mean for RLRL therapy? 🌍 πŸ“– Read the full article here: zurl.co/Hh6hA πŸ’¬ If you're an ECP - What do you think? #myopia #optometry #RLRL

πŸ’‘ China has reclassified Red Light Therapy for myopia, meaning existing treatments are no longer approved. But what does this mean for RLRL therapy? 🌍

πŸ“– Read the full article here: zurl.co/Hh6hA 

πŸ’¬ If you're an ECP - What do you think? 

#myopia #optometry #RLRL
Occuity (@occuity) 's Twitter Profile Photo

πŸ’¬ How much does myopia management cost in the UK & Ireland? We're building a clearer picture. If you offer myopia treatments, take 2 minutes to share your pricing insight. #myopiamanagement #costs #survey #optometry #myopiacontrol zurl.co/4OEXQ

πŸ’¬ How much does myopia management cost in the UK &amp; Ireland? We're building a clearer picture. If you offer myopia treatments, take 2 minutes to share your pricing insight.

#myopiamanagement #costs #survey #optometry #myopiacontrol

zurl.co/4OEXQ
Occuity (@occuity) 's Twitter Profile Photo

We're proud to share that Occuity has been recognised as part of a landmark Β£6 billion UK-India trade announcement, highlighting our recent collaboration with leading Indian medtech company Remidio. zurl.co/JPLmv #UKIndia #Medtech #Healthcare #Myopia #AX1 #PM1

We're proud to share that Occuity has been recognised as part of a landmark Β£6 billion UK-India trade announcement, highlighting our recent collaboration with leading Indian medtech company Remidio.

zurl.co/JPLmv 

#UKIndia #Medtech #Healthcare #Myopia #AX1 #PM1